SAN DIEGO (GenomeWeb News) – Complete Genomics plans to offer its wholesale human genome sequencing services to direct-to-consumer genomics companies and may obtain CLIA-certification for its genome center as part of a longer-term business plan, company officials said this week.
At the Cambridge Healthtech Institute Next-Generation Sequencing conference in San Diego, Complete Genomics Vice President Jennifer Turcotte told GenomeWeb Daily News sister publication In Sequence that the company has been watching personal genomics companies develop and would like to sequence human genomes on their behalf in the future. "That is going to be part of our business longer term," Turcotte said.
Part of the plan is to have Complete Genomics' genome center CLIA-certified, she said — a "roadmap item" for late 2009 or early 2010.
Right now, Complete Genomics provides human genome sequencing services for pilot research studies with early-access customers, including the Broad Institute and the Institute for Systems Biology, and plans to roll out its service for research customers this June.
The company also has been approached by firms that provide personal genomics information directly to consumers, Turcotte said, but had to turn them down for now. "We are looking longer term how to be a channel for these personal genomics companies, but that is not a 2009 goal," she said.
With the exception of Knome, most DTC genomics companies, which also include 23andMe, Navigenics, and DNADirect, among others, currently provide genotyping information to its customers, but several have said their long-term goal is to switch to sequencing.
A more comprehensive version of this article will appear in next week's issue of In Sequence.